Scienture Holdings (SCNX) Assets Average (2014 - 2026)
Scienture Holdings' (SCNX) quarterly Assets Average came in at $84.2 million in Q2 2026, little changed year-over-year from $84.2 million in Q2 2025, and up 2.16% quarter-over-quarter from $82.4 million in Q1 2026.
Analysis
Scienture Holdings (SCNX) Assets Average (2014 - 2026) Analysis & Trends
Scienture Holdings has disclosed Assets Average across 13 years of filings, most recently posting $84.2 million for Q2 2026.
- In Q2 2026, Assets Average changed 0.02% year-over-year to $84.2 million; the TTM figure through Jun 2026 stood at $84.2 million (changed 0.02% YoY), while the FY2025 annual figure was $94.5 million, up 61.03% from the prior year.
- Assets Average came in at $84.2 million for Q2 2026 at Scienture Holdings, up from $82.4 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $94.5 million in Q1 2025 to a low of $3.9 million in Q1 2023.
- Average Assets Average over 5 years is $37.4 million, with a median of $15.4 million recorded in 2023.
- Year-over-year, Assets Average slumped 40.44% in 2022 and jumped 1415.1% in 2024.
- Over 5 years, Assets Average stood at $4.1 million in 2022, then soared by 317.4% to $17.1 million in 2023, then surged by 250.14% to $59.9 million in 2024, then jumped by 40.65% to $84.2 million in 2025, then increased by 0.02% to $84.2 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $84.2 million in Q2 2026, $82.4 million in Q1 2026, and $84.2 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 39.95 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 35.94 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 6.21 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 3.66 Bn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 24.65 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 1.46 Bn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 1.50 Bn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 1.70 Bn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 73.15 Mn |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | 84.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 84.20 Mn |
| Mar 31, 2026 | 82.42 Mn |
| Jun 30, 2025 | 84.18 Mn |
| Mar 31, 2025 | 94.52 Mn |
| Jun 30, 2024 | 59.85 Mn |
| Mar 31, 2024 | 58.69 Mn |
| Dec 31, 2023 | 17.09 Mn |
| Sep 30, 2023 | 13.66 Mn |
| Jun 30, 2023 | 4.86 Mn |
| Mar 31, 2023 | 3.87 Mn |
| Dec 31, 2022 | 4.10 Mn |
| Sep 30, 2022 | 5.08 Mn |
| Jun 30, 2022 | 5.76 Mn |
| Mar 31, 2022 | 5.80 Mn |
| Dec 31, 2021 | 5.64 Mn |
| Sep 30, 2021 | 6.21 Mn |
| Jun 30, 2021 | 8.29 Mn |
| Mar 31, 2021 | 9.74 Mn |
| Dec 31, 2020 | 10.82 Mn |
| Sep 30, 2020 | 11.79 Mn |